The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Aasen Thomas H since 2006.
The trader's CIK number is 1291969.
At the time of the last reporting, Aasen Thomas H was the Vice Pres., CFO, Tre of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | ACAD | 0 | $0 | 45,000 | $1,083,600 | 29,500 | $45,725 |
| 2013 | ACAD | 0 | $0 | 170,000 | $2,794,790 | 165,529 | $325,041 |
| 2012 | ACAD | 0 | $0 | 40,000 | $240,621 | 17,500 | $24,150 |
| 2008 | ACAD | 0 | $0 | 8,000 | $86,904 | 13,000 | $14,040 |
| 2007 | ACAD | 0 | $0 | 28,000 | $386,732 | 11,000 | $11,880 |
| 2006 | ACAD | 0 | $0 | 36,000 | $415,920 | 4,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-04-04 | ACAD | Option Ex | 7,500 | 1.55 | 11,625 |
| 2014-04-04 | ACAD | Sale | 15,000 | 22.48 | 337,260 |
| 2014-01-02 | ACAD | Option Ex | 22,000 | 1.55 | 34,100 |
| 2014-01-02 | ACAD | Sale | 30,000 | 24.88 | 746,340 |
| 2013-12-12 | ACAD | Option Ex | 12,000 | 4.25 | 51,000 |
| 2013-10-01 | ACAD | Option Ex | 22,500 | 4.25 | 95,625 |
| 2013-10-01 | ACAD | Sale | 30,000 | 27.87 | 836,130 |
| 2013-08-13 | ACAD | Sale | 60,000 | 20.15 | 1,209,180 |
| 2013-08-13 | ACAD | Option Ex | 45,000 | 1.55 | 69,750 |
| 2013-04-11 | ACAD | Option Ex | 34,029 | 1.54 | 52,506 |
| 2013-04-11 | ACAD | Sale | 40,000 | 11.06 | 442,400 |
| 2013-04-01 | ACAD | Option Ex | 40,000 | 1.08 | 43,200 |
| 2013-04-01 | ACAD | Sale | 40,000 | 7.68 | 307,080 |
| 2013-01-17 | ACAD | Option Ex | 12,000 | 1.08 | 12,960 |
| 2012-11-27 | ACAD | Sale | 30,900 | 6.24 | 192,846 |
| 2012-11-28 | ACAD | Sale | 9,100 | 5.25 | 47,775 |
| 2012-11-28 | ACAD | Option Ex | 5,000 | 1.08 | 5,400 |
| 2012-09-07 | ACAD | Option Ex | 7,500 | 1.50 | 11,250 |
| 2012-08-03 | ACAD | Option Ex | 5,000 | 1.50 | 7,500 |
| 2008-02-13 | ACAD | Sale | 8,000 | 10.86 | 86,904 |
| 2008-02-13 | ACAD | Option Ex | 8,000 | 1.08 | 8,640 |
| 2008-02-14 | ACAD | Option Ex | 5,000 | 1.08 | 5,400 |
| 2007-12-06 | ACAD | Option Ex | 4,000 | 1.08 | 4,320 |
| 2007-12-07 | ACAD | Option Ex | 2,000 | 1.08 | 2,160 |
| 2007-12-06 | ACAD | Sale | 4,000 | 12.03 | 48,100 |
| 2007-11-14 | ACAD | Sale | 8,000 | 11.22 | 89,736 |
| 2007-11-15 | ACAD | Option Ex | 5,000 | 1.08 | 5,400 |
| 2007-08-15 | ACAD | Sale | 16,000 | 15.56 | 248,896 |
| 2006-08-24 | ACAD | Sale | 8,000 | 8.00 | 64,000 |
| 2006-08-24 | ACAD | Option Ex | 4,000 | .00 | 0 |
| 2006-05-18 | ACAD | Sale | 8,000 | 10.67 | 85,360 |
| 2006-05-18 | ACAD | Sale | 8,000 | 10.67 | 85,360 |
| 2006-02-15 | ACAD | Sale | 12,000 | 15.10 | 181,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aasen Thomas H (Vice Pres., CFO, Tre of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.